| 注册
首页|期刊导航|中国药业|415例介入治疗患者抗菌药物预防使用情况分析

415例介入治疗患者抗菌药物预防使用情况分析

王怡苹 秦侃 汪永宏 范鲁雁

中国药业Issue(13):48-49,50,3.
中国药业Issue(13):48-49,50,3.

415例介入治疗患者抗菌药物预防使用情况分析

Prophylactic Use Situation of Antibacterial Drugs in 415 Cases of Intervention Therapy

王怡苹 1秦侃 1汪永宏 1范鲁雁1

作者信息

  • 1. 安徽省合肥市第一人民医院,安徽 合肥 230001
  • 折叠

摘要

Abstract

Objective To investigate the perioperative prophylactic antibacterial drug use in the patients with intervention surgery and to analyze the existing problems. Methods The retrospective analysis was performed to investigate the perioperative antibacterial drug use in the patients with intervention surgery from January to December 2012. The cases of original infection treated by the antibacterial drugs were excluded and at the same time the intervention management was implemented. Results A total of 415 cases were monitored, 27 cases used the prophylactic antibacterial drugs with the use rate of 6. 51%,the medication time ranged 1-7 d, average 1. 78 d. The top 5 of antibacterial drug use frequency in turn were cefamandole, cefoxitin, penicillin, cefoperazone tazobactam and cephradine. Conclusion The use of perioperative prophylactic antibacterial drug use in the patients undergoing intervention surgery is basically rea-sonable, but there are still some conditions such as too long time of antibacterial drug use and incorrect selection of antibacterial drugs, which needs to further increase the clinical doctors' understanding on the use knowledge of prophylactic antibacterial drugs for enhanc-ing the rationality of prophylactic antibacterial drug use.

关键词

介入手术/抗菌药物/合理用药

Key words

intervention surgery/antibacterial drug/rational use

分类

医药卫生

引用本文复制引用

王怡苹,秦侃,汪永宏,范鲁雁..415例介入治疗患者抗菌药物预防使用情况分析[J].中国药业,2014,(13):48-49,50,3.

基金项目

安徽省“十二五”临床重点培育专科基金资助项目,项目编号卫科秘[2013]228号。 ()

中国药业

1006-4931

访问量0
|
下载量0
段落导航相关论文